WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd Stock
The WAVE Life Sciences Ltd price is unchanged compared to yesterday.
With 17 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is a positive potential of 21.43% for WAVE Life Sciences Ltd compared to the current price of 14.0 €.
So far the community has only identified positive things for WAVE Life Sciences Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 0.000% | 118.750% | 133.333% | 7.692% | 14.754% | 217.821% | 83.007% |
| Intellia Therapeutics Inc | 1.590% | -6.699% | 2.753% | -37.471% | -32.354% | -78.838% | -82.083% |
| Chromadex Corp | -1.800% | 0.000% | -4.310% | -4.310% | 7.767% | 271.113% | 32.143% |
| Polynovo Ltd | -2.210% | 0.758% | 5.556% | -45.041% | -45.041% | -48.047% | -71.581% |
Comments
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at B. Riley.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $12.00 to $34.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Show more
Ratings data for WVE provided by MarketBeat